Research Output per year
Research Output 2015 2019
2019
Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.Research output: Contribution to journal › Article
Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
7
Citations
(Scopus)
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R., Polley, M-Y., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3Research output: Contribution to journal › Article
Open Access
Follicular Lymphoma
T-cells
T-Lymphocyte Subsets
T-Lymphocytes
Survival
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies
Kourelis, T., Villasboas Bisneto, J. J. C. ., Jessen, E., Dasari, S., Dispenzieri, A., Jevremovic, D. & Kumar, S. K., Sep 1 2019, In : Blood cancer journal. 9, 9, 72.Research output: Contribution to journal › Article
Open Access
Tumor Microenvironment
T-Lymphocytes
Amyloidosis
Clonal Evolution
Tumor Escape
3
Citations
(Scopus)
Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
Pophali, P. A., Timm, M. M., Mangaonkar, A. A., Shi, M., Reichard, K., Tefferi, A., Pavelko, K., Villasboas Bisneto, J. J. C. ., Jevremovic, D. & Patnaik, M. M., Sep 1 2019, In : Blood cancer journal. 9, 9, 65.Research output: Contribution to journal › Letter
Open Access
Leukemia, Myelomonocytic, Chronic
Monocytes
Flow Cytometry
4
Citations
(Scopus)
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma
Jalali, S., Price-Troska, T., Bothun, C., Villasboas Bisneto, J. J. C. ., Kim, H. J., Yang, Z. Z., Novak, A. J., Dong, H. M. & Ansell, S. M., Mar 1 2019, In : Blood cancer journal. 9, 3, 22.Research output: Contribution to journal › Article
Hodgkin Disease
Cell Survival
Growth
Ligands
Cell Line
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
Chen, Y. P., Kim, H. J., Wu, H., Price-Troska, T., Villasboas, J. C., Jalali, S., Feldman, A. L., Novak, A. J., Yang, Z. Z. & Ansell, S. M., Oct 1 2019, In : Blood cancer journal. 9, 10, 84.Research output: Contribution to journal › Article
Open Access
Follicular Lymphoma
Monocytes
Macrophages
Cytophagocytosis
Proteins
3
Citations
(Scopus)
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas
Tracy, S. I., Larson, M. C., Feldman, A. L., Maurer, M. J., Novak, A. J., Slager, S. L., Villasboas Bisneto, J. J. C. ., Allmer, C., Habermann, T. M., Farooq, U., Syrbu, S., Cerhan, J. R. & Link, B. K., Jun 1 2019, In : American journal of hematology. 94, 6, p. 658-666 9 p.Research output: Contribution to journal › Article
B-Cell Lymphoma
Disease-Free Survival
Follicular Lymphoma
Mortality
Lymphoma
2018
Next-generation immunotherapy in Lymphoma: Checkpoint blockade, chimeric antigen receptor T cells, and beyond
Villasboas Bisneto, J. J. C. ., Jan 5 2018, The Basics of Cancer Immunotherapy. Springer International Publishing, p. 95-114 20 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
T-Cell Antigen Receptor
Immunotherapy
Lymphoma
6
Citations
(Scopus)
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
Jalali, S., Price-Troska, T., Paludo, J., Villasboas, J., Kim, H. J., Yang, Z. Z., Novak, A. J. & Ansell, S. M., Aug 14 2018, In : Blood Advances. 2, 15, p. 1985-1997 13 p.Research output: Contribution to journal › Article
Open Access
Waldenstrom Macroglobulinemia
Ligands
T-Lymphocytes
Interleukin-6
Bone Marrow
2017
18
Citations
(Scopus)
Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Chen, Y. P., Price-Troska, T. P., Jalali, S., Wilson, M., Novak, A. J. & Ansell, S. M., Sep 1 2017, In : Oncotarget. 8, 37, p. 61425-61439 15 p.Research output: Contribution to journal › Article
Follicular Lymphoma
T-Lymphocytes
Cytokines
Population
T-Cell Lymphoma
1
Citation
(Scopus)
Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib
Sorenson, K. R., Piovezani Ramos, G., Villasboas Bisneto, J. J. C. . & Price, K., May 5 2017, In : Case Reports in Oncology. 10, 2, p. 726-731 6 p.Research output: Contribution to journal › Article
Salivary Ducts
Carcinoma
Brain
Therapeutics
Facial Pain
2016
3
Citations
(Scopus)
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome
Jatoi, A., Grudem, M. E., Dockter, T. J., Block, M. S., Villasboas Bisneto, J. J. C. ., Tan, A., Deering, E., Kasi, P. M., Mansfield, A., Botero, J. P., Okuno, S. H., Smith, D. R. & Fields, A. P., Nov 12 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-6 6 p.Research output: Contribution to journal › Article
Auranofin
Acute Pain
Paclitaxel
Pain
Area Under Curve
14
Citations
(Scopus)
Checkpoint inhibition: Programmed cell death 1 and programmed cell death 1 ligand inhibitors in Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Jan 1 2016, In : Cancer Journal (United States). 22, 1, p. 17-22 6 p.Research output: Contribution to journal › Article
CD274 Antigen
Hodgkin Disease
Cell Death
Programmed Cell Death 1 Ligand 2 Protein
Programmed Cell Death 1 Receptor
14
Citations
(Scopus)
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study
Sharma, A., Jasim, S., Reading, C. C., Ristow, K. M., Villasboas Bisneto, J. J. C. ., Habermann, T. M., Fatourechi, V. & Stan, M., Aug 1 2016, In : Thyroid. 26, 8, p. 1061-1067 7 p.Research output: Contribution to journal › Article
Lymphoma
Thyroid Gland
Cohort Studies
Biopsy
Hashimoto Disease
1
Citation
(Scopus)
Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma*
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Oct 28 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-3 3 p.Research output: Contribution to journal › Article
Cellular Microenvironment
Hodgkin Disease
T-Lymphocytes
Initial presentation of CNS-restricted acute lymphoblastic B cell leukaemia as peripheral polyneuropathy
Ramos, G. P., Villasboas Bisneto, J. J. C. ., Chen, D. & Pardanani, A. D., Apr 19 2016, In : BMJ Case Reports. 2016, 600.Research output: Contribution to journal › Article
B-Cell Leukemia
Polyneuropathies
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Central Nervous System
B-Lymphocytes
11
Citations
(Scopus)
Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Jan 2 2016, In : Expert Review of Anticancer Therapy. 16, 1, p. 5-12 8 p.Research output: Contribution to journal › Article
Programmed Cell Death 1 Receptor
Hodgkin Disease
Stem Cells
Transplants
Patient Safety
4
Citations
(Scopus)
Recent advances in the management of Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., 2016, In : F1000Research. 5, 768.Research output: Contribution to journal › Review article
Hodgkin Disease
Pharmaceutical Preparations
Chemotherapy
Immune system
Radiotherapy
42
Citations
(Scopus)
Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective
Villasboas Bisneto, J. J. C. ., Ansell, S. M. & Witzig, T. E., Mar 15 2016, In : Oncotarget. 7, 11, p. 13260-13264 5 p.Research output: Contribution to journal › Article
Hodgkin Disease
Stem Cells
Transplants
Stem Cell Transplantation
Graft vs Host Disease
43
Citations
(Scopus)
The use of pembrolizumab for the treatment of metastatic uveal melanoma
Kottschade, L. A., Mc Williams, R. R., Markovic, S. N., Block, M. S., Villasboas Bisneto, J. J. C. ., Pham, A. Q., Esplin, B. L. & Dronca, R. S., Feb 4 2016, (Accepted/In press) In : Melanoma Research.Research output: Contribution to journal › Article
Therapeutics
Uveal melanoma
pembrolizumab
Central Nervous System Diseases
Disease-Free Survival
4
Citations
(Scopus)
Transition of care for inpatient hematology patients receiving chemotherapy: Development of hospital discharge huddle process and effects of implementation
Warsame, R., Kasi, P. M., Villasboas Bisneto, J. J. C. ., Gallenberg, D., Wolf, R., Ward, J., Matt-Hensrud, N., Grethen, K., Colborn, L., Zeldenrust, S., Lacy, M. & Thompson, C. A., Jan 1 2016, In : Journal of Oncology Practice. 12, 1, p. e88-e94Research output: Contribution to journal › Article
Patient Transfer
Hematology
Inpatients
Checklist
Telephone
2015
Pseudomyxoma pleuri a rare manifestation of an uncommon disease
Del Valle Somiedo Gutiérrez, M., Villasboas Bisneto, J. J. C. ., Lee, C. U., Johnson, G. B., Shen, R. K. & Maldonado, F., Jun 1 2015, In : American Journal of Respiratory and Critical Care Medicine. 191, 11, p. 1334-1335 2 p.Research output: Contribution to journal › Article
Pleural Neoplasms
Mucinous Adenocarcinoma
Myxoma
X Ray Computed Tomography
Pleura
The era of immuno-oncology: Are we there yet?
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Mar 15 2015, In : ONCOLOGY (United States). 29, 3Research output: Contribution to journal › Article
The era of immuno-oncology: are we there yet?
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Mar 1 2015, In : Oncology (Williston Park, N.Y.). 29, 3, p. 204-205 2 p.Research output: Contribution to journal › Comment/debate
Therapeutic targets and investigated strategies for treating B-cell non-Hodgkin lymphoma
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Aug 1 2015, In : Expert Opinion on Orphan Drugs. 3, 8, p. 921-932 12 p.Research output: Contribution to journal › Article
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Therapeutics
Antigen Receptors
Antibodies